» Authors » Sevim Bavbek

Sevim Bavbek

Explore the profile of Sevim Bavbek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 105
Citations 745
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Cetin G, Kepil Ozdemir S, Can Bostan O, Oztop N, Celebi Sozener Z, Karakaya G, et al.
Tuberk Toraks . 2023 Jun; 71(2):176-187. PMID: 37345400
Severe asthma is associated with increased use of healthcare services, significant deterioration in the quality of life, and high disease and economic burden on patients and societies. Additional treatments are...
12.
Celebi Sozener Z, Ozturk B, Aydin O, Mungan D, Bavbek S
Tuberk Toraks . 2023 Jun; 71(2):156-165. PMID: 37345398
Introduction: In patients with severe asthma, individualized treatment, and appropriate phenotyping are required to achieve control. In our study, our aim was to examine the characteristics of a specific patient...
13.
Tugay D, Top M, Aydin O, Bavbek S, Damadoglu E, Oner Erkekol F, et al.
J Med Econ . 2023 May; 26(1):720-730. PMID: 37129881
Aims: To evaluate the cost-effectiveness of standard-of-care treatment (SoC) to SoC in combination with omalizumab (OML + Soc) in patients with severe asthma using real-world prospective clinical data from four...
14.
Colak S, Erkoc M, Sin B, Bavbek S
World Allergy Organ J . 2023 Apr; 16(3):100761. PMID: 37065906
Background: Anaphylaxis is a very dynamic issue with its incidence and trigger profile changing over the years. We aimed to compile the characteristics of anaphylaxis cases diagnosed in our clinic...
15.
Bavbek S, Pur Ozyigit L, Baiardini I, Braido F, Roizen G, Jerschow E
J Allergy Clin Immunol Pract . 2022 Dec; 11(2):371-379. PMID: 36521832
No abstract available.
16.
Ozturk B, Akdemir I, Azap A, Celik G, Bavbek S, Mungan D
Asia Pac Allergy . 2022 Dec; 12(4):e35. PMID: 36452009
Background: CoronaVac, the first coronavirus disease 2019 vaccine administered in our country, was found safe in clinical trials. Objective: We aimed to reveal the rate and features of CoronaVac vaccine-associated...
17.
Yildiz R, Demirel Y, Mungan V, Aydin O, Sin B, Agca M, et al.
Tuberk Toraks . 2022 Sep; 70(3):231-241. PMID: 36164947
Introduction: To assess the incidence and course of COVID-19 in patients with severe asthma/chronic spontaneous urticaria using biological agents. Materials And Methods: A total of 202 patients (142 with asthma,...
18.
Ozturk B, Yavuz Z, Aydin O, Mungan D, Sin B, Demirel Y, et al.
Int Arch Allergy Immunol . 2022 Sep; 183(12):1281-1290. PMID: 36126640
Introduction: Data showing effectiveness of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) are limited. Methods: This is a single-center retrospective chart review of patients with EGPA treated with...
19.
Durmaz M, Celebi Sozener Z, Bavbek S
Tuberk Toraks . 2022 Apr; 70(1):93-101. PMID: 35362309
Eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome) is a rare systemic necrotizing granulomatous vasculitis in the spectrum of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Nevertheless, EGPA has specific clinical, biological...
20.
Celebi Sozener Z, Kendirlinan R, Cerci P, Ayd N O, Mungan D, Bavbek S, et al.
Asian Pac J Allergy Immunol . 2022 Mar; 41(3):186-192. PMID: 35278056
Background: Hymenoptera stings can cause systemic allergic reactions (SARs) that are prevented by venom immunotherapy (VIT). Sting challenge tests or field stings are used to evaluate the outcome of VIT....